ArticleBritish journal of cancer2020

Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy.

Alvin Kamili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.